Lab-grown nerve cells will replace those destroyed by disease – scientists hope treatment may be available in five years
It must be done in Panama, as there are regulatory issues in other places
Mikhaila Peterson’s on TEDX
carnivore.diet/ – Shawn Baker MD
Self reported health status, mostly very positive, in 2029 people following the carnivore, good results/
Dr Saladino carnivore diet –
Mikhaila Peterson’s podcast
WebMD explains what Basal Ganglia Calcification is.
The Parkinson’s Protocol – Natural Healing By Jodi Knapp. Clear Step by Step Instructions – Get The Parkinson’s Protocol For an Exclusive Discounted Price. Get it today (Recommended)
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Therapeutic Effects of Hydrogen in Animal Models of Parkinson’s Disease
In 2008, the researchers in Wisconsin, US discovered that PBM (photobiomodulation) is effective on Parkinson’s ( Liang et al., 2008 ). Click to view
Afterwards, researchers in Australia, France and Switzerland published numerous research studies that PBM can reduce the symptoms of MPTP and/or 6-OHDA and alpha-synuclein in the animal model with Parkinson’s (Johnstone et al., 2016 ). Click to view
In 2016, the study on PBM having an effect on monkey model with Parkinson’s has been published in the Annals of Neurology in the American Journal of Neurology. Click to view
In this study, optical fiber devices with visible red light (670 nm) were planted in the brain and MPTP injections were given for a week. In this treatment, the majority of monkeys reversed the symptoms. ( Darlot et al., 2016 ).
Red light (670 nm) was used in this study, but near-infrared light (810 nm) was also used in other studies. Usually light is administered either as a span or as a straight line to the head through percutaneous fibers, but one study suggests that it has a remote neurological protection effect on the brain and that photobiotics may be better represented. ( Johnstone et al., 2014 , Kim et al 2017 ).
Please click here to read more studies on PBM therapy and Parkinson’s
We reviewed computerized tomograms (CT) for basal ganglia and dentate nucleus calcifications in 79 patients with Parkinson’s disease (PD), 54 patients with Alzheimer’s disease (AD) and 109 controls aged 50 or more. When it was determined, no patient had disturbances in calcium metabolism. We found: …
Pharma company also plans to investigate psychedelic therapies for multiple sclerosis
In this article, our experts discuss the potential applications for a Parkinson’s Disease simulator to inform decision-making and strategic planning early in the development of disease modifying therapies (DMTs)
Stem cell therapy for autism, cerebral palsy, heart failure, multiple sclerosis, osteoarthritis, rheumatoid arthritis, and spinal cord injury.
Fountain Life brings together the world’s most renowned medical and health experts to boost longevity and performance. Our goal is to educate our members and empower them to be proactive about their health. We help our members operate at peak performance throughout their lifespan! We strive to help our members make 100 the new 60.
A chronic progressive CNS disorder characterized by slowness of purposeful movement, resting tremors, and muscle rigidity. Also called “Parkinsonism” and “Paralysis Agitans” Dorland’s Medical Dictionary describes the Parkinsonian complex as “neurologic disorders characterized by hypokinesia, tremors and muscular rigidity. It typically occurs late in life, although juvenile forms have been described.” The diagnosis for their disorder is made from the
92 patients with Parkinson’s disease not previously treated with levodopa were considered as eligible for this triple-blind trial. Patients were allocated at random to treatment with either levodopa + benserazide ratio 4:1 (Madopar) or levodopa + carbidopa ratio 10:1 (Sinemet) using dosage schedules …